DXCM241206P75000
- 0.10
- -0.20-66.67%
DexCom Newsroom
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
Unusual Options Activity: PINS, MCHP and Others Attract Market Bets, PINS V/OI Ratio Reaches 333.3
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
United States Diabetes Device Market Forecast Report and Company Analysis 2024-2032 Featuring BD, Roche, Medtronic, Insulet, Abbott, Dexcom, Tandem Diabetes Care, Ypsomed Novo Nordisk, Eli Lilly - ResearchAndMarkets.com
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
December Starts With a Mixed Market | Live Stock
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
The Return Trends At DexCom (NASDAQ:DXCM) Look Promising
Is DexCom, Inc. (NASDAQ:DXCM) Potentially Undervalued?
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024?
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed
S&P 500, Dow Hit Records Right After Open | Live Stock